Isodiol International Inc (OTCMKTS: ISOLF) Loses Ground


Isodiol International Inc (OTCMKTS: ISOLF) continues to lose ground in recent weeks since a pop over $4 per share back in September.

The Company operates in the red hot CBD space that recently after a Bloomberg article claimed Coca-Cola is monitoring the nascent industry and is interested in drinks infused with CBD. Cannabis stocks have been booming in recent months as we near legal recreational cannabis in Canada on October 17.

Isodiol International Inc (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) is a growth through acquisition story; Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its consumer products portfolio and aggressively continue international expansion into Latin America, Asia, and Europe.

Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products. Most recently, the Company received approval for its CBD designated as an Active Pharmaceutical Ingredient for use in Finished Pharmaceutical Products, as was announced on April 26, 2018.

Isodial is seeing significant growth; the Company recently reported first quarter revenue of $9.2 million, representing an approximate 240% increase over the quarter ended June 30, 2017 and an approximate 70% increase over revenues of $5.4 million in the fourth quarter of fiscal 2018.

2018 has been a big year for Isodiol; they received government Approval from United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) for Pure, Natural CBD as an Active Pharmaceutical Ingredient (API) They Completed the Acquisition of KURE Corp and also announced KURE expansion plans.

In May they acquired a turn-key brewing system, including a 7-bbl brewhouse, four 15-bbl fermentation tanks, a 30-bbl fermentation tank, a 15-bbl brite tank, and a 30-bbl brite tank, which is expected to yield between 1,500 and 2,000 bbls of production per year.  In addition, IsoBev acquired a 12-ounce bottling line and a 22-ounce bottling line, which could yield over 600,000 12-oz bottles and 25,000 12-oz bottle cases per year.

To Find out the inside Scoop on Isodiol Subscribe to Right Now by entering your Email in the box below

The Company also launched ISOCare in North American and Latin American markets in conjunction with Livecare. ISOCare is an innovative secure platform for the cannabis treatment industry that enables and supports physicians in the longitudinal care of their patients’ health. The Company had previously announced its licensing agreement with Livecare on January 26, 2018.

ISOCare will allow collaborative care with doctors and mentor certified cannabis practitioners to achieve health outcomes including medicinal cannabis therapies. The ISOCare platform connects patients with providers for a medical visit, through a mobile or PC device, eliminating many of the inconveniences faced today in the physician and patient relationship. To access the ISOCare platform, patients must simply complete their initiation form, which doctors then review before connecting with patients via video conference. From there, physicians may prescribe medications, or discuss any other concerns. Last month Isodiol entered into an agreement with Powerhouse Gym, one of the largest health club licensing organization in the world, through the Company’s wholly owned subsidiary, Iso-Sport, to be the preferred vendor of CBD Performance Products offered to its over 1.2 million gym members1.

On October 22 provided an update on its recently acquired Florida based bottler, Azure.  The Company is planning for increased warehousing capabilities and expansion of the production facility located in Leesburg, Florida.

IsoBev is the Company’s division that focuses on growing its beverage brand portfolio and contract manufacturing services for the beverage industry.  With the expansion of the Leesburg warehouse, the Company will be able to facilitate its distribution needs in the South East market and provide Azure additional space to increase production for its customers that include Sysco, McArthur Dairy and Dean Foods. The Company is also preparing to expand its beverage production capabilities for bottling in Leesburg to include a sparkling line and flavored line to meet the increased demands for functional beverages that include CBD.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $51 million market valuation Isodiol has $11.5 million in the treasury, $32 million in current assets and significant debt with $63 million in current liabilities. Isodiol is an exciting Company that has seen explosive growth through acquisition recently reported first quarter revenue of $9.2 million, representing an approximate 240% increase over the quarter ended June 30, 2017 and an approximate 70% increase over revenues of $5.4 million in the fourth quarter of fiscal 2018. The stock has quickly attracted a loyal shareholder base who continues to bid this one higher. We will be updating on Isodiol when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Isodiol.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in Isodiol either long or short and we have not been compensated for this article.


Leave A Reply

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.